Amgen Slashes the Price of a Promising Cholesterol Drug

Thursday, October 25, 2018 - 16:20 in Mathematics & Economics

The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net